MARS - Does it stand the test of time?

Metabolic Brain Disease

Volumn 19, Issue 3-4, 2004, Pages 223-228

  Mullen, Kevin D ^a   Dasarathy, Srinivasan ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

albumin dialysis; Artificial liver support; liver failure

Indexed keywords

ALBUMIN;

ARTIFICIAL LIVER; CLINICAL TRIAL; CONFERENCE PAPER; DIALYSIS; EXTRACORPOREAL ALBUMIN DIALYSIS; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; MOLECULAR ABSORBENT RECYCLING SYSTEM;

ALBUMINS; CLINICAL TRIALS; HUMANS; LIFE SUPPORT SYSTEMS; LIVER FAILURE, ACUTE; LIVER, ARTIFICIAL; RENAL DIALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 5444272357     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MEBR.0000043972.50878.f0     Document Type: Conference Paper

References (16)

1. Clements, W.D., McCaigue, M., Erwin, P., Halliday, I., and Rowlands, B.J. (1996). Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 38:925-931.
2. Haussinger, D., Kircheis, G., Fischer, R., Schleiss, F., and VomDahl, S. (2000). Hepatic encephalopathy a chronic liver disease: A manifestation of low grade cerebral edema. J. Hepatol. 32:1035-1038.
3. Heemann, U., Treichel, U., Loock, J., Philipp, T., Gergen, G., et al. (2002). Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 36:949-958.
4. Huster, D., Schubert, C., Achenbach, H., Caca, K., Mossner, J., and Berr, F. (2001). Successful clinical application of extracorporeal albumin in dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC). Z. Gastroenterol. 39(Suppl.):13-14.
5. Kamath, P.S. (2002). Is there life in MARS? Hepatology 36:1017-1019.
6. Mitzner, S., Stange, I., Klammt, S., et al. (2000). Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, controlled clinical trial. Liver Transpl. 6:277-286.
7. Mitzner, S.R., Klammt, S., Peszynski, P., Kikstein, H., Korker, G., Stange, J., and Schmidt, R. (2001). Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular absorbent recirculating system. Ther. Apher. 29:1332-1336.
8. Moreau, R., Durand, F., Poynard, T., et al. (2002). Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study. Gastroenterology 122:923-930.
9. Mullen, K.D. (2002). Treatment of hepatorenal syndrome. Lessons from the MARS Trial. Hepatology 35:492-493.
10. Novelli, G., Arossi, M., Pretagostini, R., et al. (2001). Use of MARS in the treatment of acute liver failure: Preliminary monocentric experience. Transplant. Proc. 33:3480-3482.
11. Schmidt, L.E., Svendsen, L.P., Sorensen, V.R., Hansen, B.A., and Larsen, F.S. (2001a). Cerebral blood flow velocity increases during a single treatment with the Molecular Adsorbents Recirculating System in patients with acute on chronic liver failure. Liver Transpl. 7:709-712.
12. Schmidt, L.E., Svendsen, L.P., Sorensen, V.R., Hansen, B.A., and Larsen, F.S. (2001b). Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl. 7:1034-1039.
13. Sen, S., Jalan, R., and Williams, R. (2002a). Extracorporeal albumin dialysis in acute-on-chronic liver failure: Will it stand the test of time? Hepatology 36:1014-1016.
14. Sen, S., Mookerjee, R.P., Davies, N.A., Williams, R., and Jalan, R. (2002b). Review article: The molecular adsorbents recirculating system (MARS) in liver failure. Ali. Pharmacol. Ther. 16:32-38.
15. Stange, J., Ramlow, W., Mitzner, S., Schmidt, R., and Klinkmann, H. (1993). Dialysis against a recycled albumin-bound toxins. Artif. Organs 17:809-813.
16. Stange, J., and Mitzner, S. (1996). A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patient's blood and a bioartificial liver. Int. J. Artif. Organs 19:677-691.